Reflect Scientific, Inc. Completes Another Sale of Its Cryometrix Freezer to a Biopharmaceutical...

Reflect Scientific, Inc. Completes Another Sale of Its Cryometrix Freezer to a Biopharmaceutical Company

OREM, Utah--(Business Wire)--Reflect Scientific, Inc. (OTCBB: RSCF), announces that Cryometrix,
a wholly owned subsidiary of Reflect Scientific, has completed the
sale and shipment of another Ultra Low Temperature (ULT) freezing
system to a West Coast biopharmaceutical company.

According to a Reflect Scientific representative, the sale and
shipment of the ULT freezing system represents the success of a
testing program conducted by the biopharmaceutical company on the ULT
freezing system. During the testing program, the freezing system
underwent a rigorous evaluation, which resulted in the sale. ULT
freezing systems are sophisticated and costly; thus often, the
installation requires customer assessment prior to purchase and
implementation.

Cryometrix, a wholly owned subsidiary of Reflect Scientific,
develops, manufactures and markets refrigeration and cryogenic
preservation equipment. The ULT model T-150 is an "all in one" cooling
and cryogenic freezing system. It is the first liquid nitrogen based,
programmable cooling and cryogenic freezing system in a standard
upright format, which allows for exceptional reliability, precise
thermal uniformity, and no user or product exposure to liquid
nitrogen. The Cryometrix freezer is optimized for bio-repositories,
research, forensic, hospital and clinical laboratories, and other life
science applications where refrigeration and cryogenic preservation is
required.

"This is another step in the commercialization of the model T-150
ULT freezer as a single unit, multi-technique system. The flexibility
and capabilities of the T-150 is a major selling point in the system
having the ability to handle short term storage, long term-low
temperature permanent storage and large-capacity lyophilization. This
particular delivery will enable our client to address several critical
points in the cold chain management of their biopharmaceutical
manufacturing process and hopefully will become their technology of
choice as they expand their operations. The fact that the T-150
freezer can also serve as a shipping system is a very important
development as it now provides a reliable means for bulk cryogenic
temperature controlled transportation of biopharmaceuticals and other
cold storage products," remarked Dr. Boyd Bowdish, Director of
Cryometrix.

Reflect Scientific and its subsidiaries provide diverse scientific
products and services for the biotechnology, pharmaceutical and
medical industries.

Cautionary Note Regarding Forward-Looking Statements:

Forward-looking statements in this release are made pursuant to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Investors are cautioned that such forward-looking
statements involve risks and uncertainties, including without
limitation, continued acceptance of the Company's products, increased
levels of competition for the Company, new products and technological
changes, the Company's dependence on third-party suppliers, and other
risks detailed from time to time in the Company's periodic reports
filed with the Securities and Exchange Commission.

For information related to Reflect Scientific, contact Investor
Relations: Michael Dancy, 801-746-3570, email: medancy@allwest.net, or
visit: www.reflectscientific.com.

Reflect Scientific
Michael Dancy, 801-746-3570 (Investor Relations)
medancy@allwest.net

Copyright Business Wire 2008